Livomedrox
THERAPEUTIC AREA: Oncology
ACTIVE PRINCIPLE: Medroxyprogesterone
PRESENTATION: 500 mg x 20 capsules
INDICATION:
- Renal or Endometrial Carcinoma
COUNTRIES WHERE IT IS MARKETED:
